APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cognitive Behavioral Therapy for Insomnia

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cognitive Behavioral Therapy for Insomnia Market Analysis and Forecast 2026-2032

5 July 2026173 pages

Choose your research edition.

Industry ResearchCognitive Behavioral Therapy for Insomnia Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cognitive Behavioral Therapy for Insomnia Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cognitive Behavioral Therapy for Insomnia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cognitive Behavioral Therapy for Insomnia Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cognitive Behavioral Therapy for Insomnia Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global Cognitive Behavioral Therapy for Insomnia market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cognitive Behavioral Therapy for Insomnia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cognitive Behavioral Therapy for Insomnia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cognitive Behavioral Therapy for Insomnia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cognitive Behavioral Therapy for Insomnia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cognitive Behavioral Therapy for Insomnia include MINERVA NEUROSCIENCES INC, CURRAX PHARMACEUTICALS LLC, Pfizer Inc., Sanofi, zydus cadila, Vanda Pharmaceuticals Inc., EISAI,, merck kgaa and darmstadt, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cognitive Behavioral Therapy for Insomnia, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cognitive Behavioral Therapy for Insomnia, also provides the revenue of main regions and countries. Of the upcoming market potential for Cognitive Behavioral Therapy for Insomnia, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cognitive Behavioral Therapy for Insomnia revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cognitive Behavioral Therapy for Insomnia market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cognitive Behavioral Therapy for Insomnia revenue, projected growth trends, production technology, application and end-user industry.

Cognitive Behavioral Therapy for Insomnia Segment by Company

MINERVA NEUROSCIENCES INC

CURRAX PHARMACEUTICALS LLC

Pfizer Inc.

Sanofi

zydus cadila

Vanda Pharmaceuticals Inc.

EISAI,

merck kgaa

darmstadt

germany

VIATRIS INC

Takeda Pharmaceutical Company

Cognitive Behavioral Therapy for Insomnia Segment by Type

Non Pharmacological Therapy

Pharmacological Therapy

Cognitive Behavioral Therapy for Insomnia Segment by Application

Mental Health Services

Sleep Clinics

Pharmaceutical Industry

Sleep-related Devices and Technology

Cognitive Behavioral Therapy for Insomnia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Behavioral Therapy for Insomnia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognitive Behavioral Therapy for Insomnia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Behavioral Therapy for Insomnia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cognitive Behavioral Therapy for Insomnia in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cognitive Behavioral Therapy for Insomnia company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cognitive Behavioral Therapy for Insomnia revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non Pharmacological Therapy Major Player Table 3. Pharmacological Therapy Major Player Table 4. Global Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Mental Health Services Major Player Table 6. Sleep Clinics Major Player Table 7. Pharmaceutical Industry Major Player Table 8. Sleep-related Devices and Technology Major Player Table 9. Cognitive Behavioral Therapy for Insomnia Industry Trends Table 10. Cognitive Behavioral Therapy for Insomnia Industry Drivers Table 11. Cognitive Behavioral Therapy for Insomnia Industry Opportunities and Challenges Table 12. Cognitive Behavioral Therapy for Insomnia Industry Restraints Table 13. Global Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cognitive Behavioral Therapy for Insomnia Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cognitive Behavioral Therapy for Insomnia Market Share by Region (2021-2026) Table 16. Global Cognitive Behavioral Therapy for Insomnia Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cognitive Behavioral Therapy for Insomnia Market Share by Region (2027-2032) Table 18. Global Cognitive Behavioral Therapy for Insomnia Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Players (2021-2026) Table 20. Global Cognitive Behavioral Therapy for Insomnia Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cognitive Behavioral Therapy for Insomnia Key Players Headquarters & Area Served Table 22. Global Cognitive Behavioral Therapy for Insomnia Players, Product Type & Application Table 23. Global Cognitive Behavioral Therapy for Insomnia Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cognitive Behavioral Therapy for Insomnia by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cognitive Behavioral Therapy for Insomnia Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Type (2021-2026) Table 30. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Type (2027-2032) Table 31. Global Cognitive Behavioral Therapy for Insomnia Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Application (2021-2026) Table 35. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Application (2027-2032) Table 36. MINERVA NEUROSCIENCES INC Company Information Table 37. MINERVA NEUROSCIENCES INC Business Overview Table 38. MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 40. MINERVA NEUROSCIENCES INC Recent Development Table 41. CURRAX PHARMACEUTICALS LLC Company Information Table 42. CURRAX PHARMACEUTICALS LLC Business Overview Table 43. CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 45. CURRAX PHARMACEUTICALS LLC Recent Development Table 46. Pfizer Inc. Company Information Table 47. Pfizer Inc. Business Overview Table 48. Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 50. Pfizer Inc. Recent Development Table 51. Sanofi Company Information Table 52. Sanofi Business Overview Table 53. Sanofi Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Sanofi Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 55. Sanofi Recent Development Table 56. zydus cadila Company Information Table 57. zydus cadila Business Overview Table 58. zydus cadila Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. zydus cadila Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 60. zydus cadila Recent Development Table 61. Vanda Pharmaceuticals Inc. Company Information Table 62. Vanda Pharmaceuticals Inc. Business Overview Table 63. Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 65. Vanda Pharmaceuticals Inc. Recent Development Table 66. EISAI, Company Information Table 67. EISAI, Business Overview Table 68. EISAI, Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. EISAI, Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 70. EISAI, Recent Development Table 71. merck kgaa Company Information Table 72. merck kgaa Business Overview Table 73. merck kgaa Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. merck kgaa Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 75. merck kgaa Recent Development Table 76. darmstadt Company Information Table 77. darmstadt Business Overview Table 78. darmstadt Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. darmstadt Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 80. darmstadt Recent Development Table 81. germany Company Information Table 82. germany Business Overview Table 83. germany Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. germany Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 85. germany Recent Development Table 86. VIATRIS INC Company Information Table 87. VIATRIS INC Business Overview Table 88. VIATRIS INC Cognitive Behavioral Therapy for Insomnia Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. VIATRIS INC Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 90. VIATRIS INC Recent Development Table 91. Takeda Pharmaceutical Company Company Information Table 92. Takeda Pharmaceutical Company Business Overview Table 93. Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Product Portfolio Table 95. Takeda Pharmaceutical Company Recent Development Table 96. North America Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Cognitive Behavioral Therapy for Insomnia Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Cognitive Behavioral Therapy for Insomnia Revenue by Country (US$ Million) & (2027-2032) Table 110. China Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026) & (US$ Million) Table 111. China Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032) & (US$ Million) Table 112. China Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026) & (US$ Million) Table 113. China Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Cognitive Behavioral Therapy for Insomnia Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Cognitive Behavioral Therapy for Insomnia Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Cognitive Behavioral Therapy for Insomnia Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Cognitive Behavioral Therapy for Insomnia Image Figure 2. Global Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cognitive Behavioral Therapy for Insomnia Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non Pharmacological Therapy Image Figure 5. Pharmacological Therapy Image Figure 6. Global Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cognitive Behavioral Therapy for Insomnia Market Size Share 2021 VS 2025 VS 2032 Figure 8. Mental Health Services Image Figure 9. Sleep Clinics Image Figure 10. Pharmaceutical Industry Image Figure 11. Sleep-related Devices and Technology Image Figure 12. Global Cognitive Behavioral Therapy for Insomnia Market Size (US$ Million) & (2021-2032) Figure 13. Global Cognitive Behavioral Therapy for Insomnia Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cognitive Behavioral Therapy for Insomnia Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cognitive Behavioral Therapy for Insomnia Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Type (2021-2032) Figure 20. Global Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Application (2021-2032) Figure 23. North America Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032) Figure 25. North America Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032) Figure 26. North America Cognitive Behavioral Therapy for Insomnia Revenue Share by Country (2021-2032) Figure 27. United States Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032) Figure 32. Europe Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032) Figure 33. Europe Cognitive Behavioral Therapy for Insomnia Revenue Share by Country (2021-2032) Figure 34. Germany Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032) Figure 44. China Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032) Figure 45. Asia Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032) Figure 47. Asia Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032) Figure 48. Asia Cognitive Behavioral Therapy for Insomnia Revenue Share by Region (2021-2032) Figure 49. Japan Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032) Figure 57. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032) Figure 58. SAMEA Cognitive Behavioral Therapy for Insomnia Revenue Share by Country (2021-2032) Figure 59. Brazil Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cognitive Behavioral Therapy for Insomnia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Non Pharmacological Therapy
  • Pharmacological Therapy
Applications
  • Mental Health Services
  • Sleep Clinics
  • Pharmaceutical Industry
  • Sleep-related Devices and Technology
Companies covered
  • MINERVA NEUROSCIENCES INC
  • CURRAX PHARMACEUTICALS LLC
  • Pfizer Inc.
  • Sanofi
  • zydus cadila
  • Vanda Pharmaceuticals Inc.
  • EISAI,
  • merck kgaa
  • darmstadt
  • germany
  • VIATRIS INC
  • Takeda Pharmaceutical Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cognitive Behavioral Therapy for Insomnia Market by Type
  3. 1.2.1 Global Cognitive Behavioral Therapy for Insomnia Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non Pharmacological Therapy
  5. 1.2.3 Pharmacological Therapy
  6. 1.3 Cognitive Behavioral Therapy for Insomnia Market by Application
  7. 1.3.1 Global Cognitive Behavioral Therapy for Insomnia Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Mental Health Services
  9. 1.3.3 Sleep Clinics
  10. 1.3.4 Pharmaceutical Industry
  11. 1.3.5 Sleep-related Devices and Technology
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cognitive Behavioral Therapy for Insomnia Market Dynamics
  1. 2.1 Cognitive Behavioral Therapy for Insomnia Industry Trends
  2. 2.2 Cognitive Behavioral Therapy for Insomnia Industry Drivers
  3. 2.3 Cognitive Behavioral Therapy for Insomnia Industry Opportunities and Challenges
  4. 2.4 Cognitive Behavioral Therapy for Insomnia Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cognitive Behavioral Therapy for Insomnia Market Perspective (2021-2032)
  2. 3.2 Global Cognitive Behavioral Therapy for Insomnia Growth Trends by Region
  3. 3.2.1 Global Cognitive Behavioral Therapy for Insomnia Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cognitive Behavioral Therapy for Insomnia Market Size by Region (2021-2026)
  5. 3.2.3 Global Cognitive Behavioral Therapy for Insomnia Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cognitive Behavioral Therapy for Insomnia Revenue by Players
  2. 4.1.1 Global Cognitive Behavioral Therapy for Insomnia Revenue by Players (2021-2026)
  3. 4.1.2 Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cognitive Behavioral Therapy for Insomnia Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cognitive Behavioral Therapy for Insomnia Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cognitive Behavioral Therapy for Insomnia Key Players Headquarters & Area Served
  7. 4.4 Global Cognitive Behavioral Therapy for Insomnia Players, Product Type & Application
  8. 4.5 Global Cognitive Behavioral Therapy for Insomnia Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cognitive Behavioral Therapy for Insomnia Market CR5 and HHI
  11. 4.6.3 2025 Cognitive Behavioral Therapy for Insomnia Tier 1, Tier 2, and Tier 3
5 Cognitive Behavioral Therapy for Insomnia Market Size by Type
  1. 5.1 Global Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2032)
  3. 5.3 Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Type (2021-2032)
6 Cognitive Behavioral Therapy for Insomnia Market Size by Application
  1. 6.1 Global Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2032)
  3. 6.3 Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 MINERVA NEUROSCIENCES INC
  2. 7.1.1 MINERVA NEUROSCIENCES INC Company Information
  3. 7.1.2 MINERVA NEUROSCIENCES INC Business Overview
  4. 7.1.3 MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  5. 7.1.4 MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Product Portfolio
  6. 7.1.5 MINERVA NEUROSCIENCES INC Recent Developments
  7. 7.2 CURRAX PHARMACEUTICALS LLC
  8. 7.2.1 CURRAX PHARMACEUTICALS LLC Company Information
  9. 7.2.2 CURRAX PHARMACEUTICALS LLC Business Overview
  10. 7.2.3 CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Product Portfolio
  12. 7.2.5 CURRAX PHARMACEUTICALS LLC Recent Developments
  13. 7.3 Pfizer Inc.
  14. 7.3.1 Pfizer Inc. Company Information
  15. 7.3.2 Pfizer Inc. Business Overview
  16. 7.3.3 Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio
  18. 7.3.5 Pfizer Inc. Recent Developments
  19. 7.4 Sanofi
  20. 7.4.1 Sanofi Company Information
  21. 7.4.2 Sanofi Business Overview
  22. 7.4.3 Sanofi Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Cognitive Behavioral Therapy for Insomnia Product Portfolio
  24. 7.4.5 Sanofi Recent Developments
  25. 7.5 zydus cadila
  26. 7.5.1 zydus cadila Company Information
  27. 7.5.2 zydus cadila Business Overview
  28. 7.5.3 zydus cadila Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  29. 7.5.4 zydus cadila Cognitive Behavioral Therapy for Insomnia Product Portfolio
  30. 7.5.5 zydus cadila Recent Developments
  31. 7.6 Vanda Pharmaceuticals Inc.
  32. 7.6.1 Vanda Pharmaceuticals Inc. Company Information
  33. 7.6.2 Vanda Pharmaceuticals Inc. Business Overview
  34. 7.6.3 Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio
  36. 7.6.5 Vanda Pharmaceuticals Inc. Recent Developments
  37. 7.7 EISAI,
  38. 7.7.1 EISAI, Company Information
  39. 7.7.2 EISAI, Business Overview
  40. 7.7.3 EISAI, Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  41. 7.7.4 EISAI, Cognitive Behavioral Therapy for Insomnia Product Portfolio
  42. 7.7.5 EISAI, Recent Developments
  43. 7.8 merck kgaa
  44. 7.8.1 merck kgaa Company Information
  45. 7.8.2 merck kgaa Business Overview
  46. 7.8.3 merck kgaa Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  47. 7.8.4 merck kgaa Cognitive Behavioral Therapy for Insomnia Product Portfolio
  48. 7.8.5 merck kgaa Recent Developments
  49. 7.9 darmstadt
  50. 7.9.1 darmstadt Company Information
  51. 7.9.2 darmstadt Business Overview
  52. 7.9.3 darmstadt Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  53. 7.9.4 darmstadt Cognitive Behavioral Therapy for Insomnia Product Portfolio
  54. 7.9.5 darmstadt Recent Developments
  55. 7.10 germany
  56. 7.10.1 germany Company Information
  57. 7.10.2 germany Business Overview
  58. 7.10.3 germany Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  59. 7.10.4 germany Cognitive Behavioral Therapy for Insomnia Product Portfolio
  60. 7.10.5 germany Recent Developments
  61. 7.11 VIATRIS INC
  62. 7.11.1 VIATRIS INC Company Information
  63. 7.11.2 VIATRIS INC Business Overview
  64. 7.11.3 VIATRIS INC Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  65. 7.11.4 VIATRIS INC Cognitive Behavioral Therapy for Insomnia Product Portfolio
  66. 7.11.5 VIATRIS INC Recent Developments
  67. 7.12 Takeda Pharmaceutical Company
  68. 7.12.1 Takeda Pharmaceutical Company Company Information
  69. 7.12.2 Takeda Pharmaceutical Company Business Overview
  70. 7.12.3 Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Product Portfolio
  72. 7.12.5 Takeda Pharmaceutical Company Recent Developments
8 North America
  1. 8.1 North America Cognitive Behavioral Therapy for Insomnia Revenue (2021-2032)
  2. 8.2 North America Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2032)
  3. 8.2.1 North America Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026)
  4. 8.2.2 North America Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032)
  5. 8.3 North America Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032)
  6. 8.4 North America Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2032)
  7. 8.4.1 North America Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026)
  8. 8.4.2 North America Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032)
  9. 8.5 North America Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032)
  10. 8.6 North America Cognitive Behavioral Therapy for Insomnia Revenue by Country
  11. 8.6.1 North America Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021-2026)
  13. 8.6.3 North America Cognitive Behavioral Therapy for Insomnia Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cognitive Behavioral Therapy for Insomnia Revenue (2021-2032)
  2. 9.2 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032)
  5. 9.3 Europe Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032)
  9. 9.5 Europe Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Country
  11. 9.6.1 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cognitive Behavioral Therapy for Insomnia Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cognitive Behavioral Therapy for Insomnia Revenue (2021-2032)
  2. 10.2 China Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2032)
  3. 10.2.1 China Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026)
  4. 10.2.2 China Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032)
  5. 10.3 China Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032)
  6. 10.4 China Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2032)
  7. 10.4.1 China Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026)
  8. 10.4.2 China Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032)
  9. 10.5 China Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cognitive Behavioral Therapy for Insomnia Revenue (2021-2032)
  2. 11.2 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032)
  5. 11.3 Asia Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032)
  9. 11.5 Asia Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Country
  11. 11.6.1 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cognitive Behavioral Therapy for Insomnia Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue (2021-2032)
  2. 12.2 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Country
  11. 12.6.1 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cognitive Behavioral Therapy for Insomnia Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst